Detalles de la búsqueda
1.
21-gene expression assay and clinical outcomes of premenopausal patients with hormone receptor-positive breast cancer.
Int J Cancer
; 154(4): 748-756, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37718333
2.
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
N Engl J Med
; 385(25): 2336-2347, 2021 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34914339
3.
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer.
Future Oncol
; 20(8): 423-436, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37387213
4.
Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in node-positive breast cancer (Neo-shorter; NCT02001506).
Breast Cancer Res Treat
; 201(2): 193-204, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37365483
5.
TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer.
Future Oncol
; 19(35): 2349-2359, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37526149
6.
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.
N Engl J Med
; 381(4): 307-316, 2019 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31166679
7.
Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning-measured Spleen Volume at CT.
Radiology
; 305(3): 606-613, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35943338
8.
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.
Lancet Oncol
; 22(1): 85-97, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33357420
9.
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study.
Lancet Oncol
; 22(7): 1034-1046, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34143970
10.
Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor-positive, HER2-negative metastatic breast cancer.
Int J Cancer
; 2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33905134
11.
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial.
Lancet
; 396(10257): 1090-1100, 2020 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32966830
12.
Oncologic Safety of Nipple-Sparing Mastectomy in Patients with Breast Cancer and Tumor-to-Nipple Distance ≤ 1 cm: A Matched Cohort Study.
Ann Surg Oncol
; 28(8): 4284-4291, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33423119
13.
Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13).
Cytokine
; 142: 155487, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33770643
14.
Impact of family caregivers' awareness of the prognosis on their quality of life/depression and those of patients with advanced cancer: a prospective cohort study.
Support Care Cancer
; 29(1): 397-407, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32372177
15.
Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib.
Breast Cancer Res Treat
; 184(3): 743-753, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32860168
16.
Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer.
J Hum Genet
; 65(3): 209-220, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31907386
17.
A pilot study on intermittent every other days of 5-dose Filgrastim compared with single Pegfilgrastim in breast Cancer patients receiving adjuvant Docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy.
Invest New Drugs
; 38(3): 866-873, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31728715
18.
Efficacy of health coaching and a web-based program on physical activity, weight, and distress management among cancer survivors: A multi-centered randomised controlled trial.
Psychooncology
; 29(7): 1105-1114, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32307828
19.
Characteristics of metastatic brachial plexopathy in patients with breast cancer.
Support Care Cancer
; 28(4): 1913-1918, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31363905
20.
Performance evaluation of an amplicon-based next-generation sequencing panel for BRCA1 and BRCA2 variant detection.
J Clin Lab Anal
; 34(12): e23524, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32812259